Patents by Inventor Miho Suzuki
Miho Suzuki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240109459Abstract: A seat cushion is formed integrally by a body pad portion, an outer peripheral edge portion, and a connection portion. The outer peripheral edge portion protrudes toward a floor panel from the outer peripheral edge portion in a plan view and contacts a floor panel at its lower face. The connection portion is provided to protrude toward the floor panel at a portion which is separated from a front-side part of the outer peripheral edge portion and a rear-side part of the outer peripheral edge portion, respectively. The connection portion connects the floor panel and the body pad portion. A portion between the front-side part and the rear-side part of the outer peripheral edge portion in a vehicle longitudinal direction is a separation portion where a lower face of the seat cushion faces an upper face of the floor panel with a gap.Type: ApplicationFiled: February 23, 2023Publication date: April 4, 2024Applicant: MAZDA MOTOR CORPORATIONInventors: Kenji MATSUMOTO, Miho KURATA, Sakayu TERADA, Daisuke YAMADA, Yuki HANAZAWA, Naoko MOTOYOSHI, Aoi FUJIMOTO, Junsuke INOUE, Takashi SUZUKI
-
Publication number: 20240034721Abstract: Provided is, as a radioactive halogen labeling precursor compound that is highly reactive and stable, a compound represented by the following general formula (II): wherein R1 and R2 each independently represent an alkyl group having 5 to 20 carbon atoms, X1 and X2 each independently represent a halogen atom, and R3 represents a monovalent group derived from a sugar, or the like.Type: ApplicationFiled: January 18, 2022Publication date: February 1, 2024Applicants: TOKYO INSTITUTE OF TECHNOLOGY, FUKUSHIMA MEDICAL UNIVERSITY, TAIYO NIPPON SANSO CORPORATIONInventors: Hiroshi TANAKA, Kazuhiro TAKAHASHI, Miho SUZUKI
-
Publication number: 20230373881Abstract: In order to produce high yields of astatine-211 without contamination of chloride ions, provided is a method for producing astatine-211, including (1) a step of generating astatine-211 by irradiating bismuth with ? rays; (2) a step of heating the astatine-211 generated in step (1) to vaporize; (3) a step of cooling the astatine-211 that has been vaporized in step (2) and collecting the astatine-211 with a volatile and polar solvent to obtain an astatine-211 solution; (4) a step of adding a weak acid salt to the astatine-211 solution obtained in step (3) to obtain an astatine-211 solution containing the weak acid salt; and (5) a step of removing the solvent from the astatine-211 solution containing the weak acid salt obtained in step (4).Type: ApplicationFiled: May 6, 2021Publication date: November 23, 2023Applicants: TOKYO INSTITUTE OF TECHNOLOGY, FUKUSHIMA MEDICAL UNIVERSITYInventors: Hiroshi TANAKA, Kazuhiro TAKAHASHI, Miho SUZUKI
-
Patent number: 11811048Abstract: A non-aqueous electrolyte solution battery includes a positive electrode containing manganese dioxide and a carbon material; a negative electrode including one of lithium and a lithium alloy; a non-aqueous electrolyte solution; and a container configured to accommodate the positive electrode, the negative electrode, and the non-aqueous electrolyte solution. In a spectrum that is measured by performing Raman spectroscopic analysis with respect to the positive electrode by using argon laser at a wavelength of 514.5 nm, an average value of peak intensity ratios ID/IG of an intensity ID of a peak appearing in the vicinity of 1330 cm?1 to an intensity IG of a peak appearing in the vicinity of 1580 cm?1 satisfies a relationship of 0.5?ID/IG?1.3.Type: GrantFiled: February 27, 2020Date of Patent: November 7, 2023Assignee: Murata Manufacturing Co., Ltd.Inventors: Kohei Watanabe, Jun Yagisawa, Miho Suzuki, Kaoru Yabuki, Koji Harada, Yushin Endo
-
Publication number: 20230241257Abstract: It is an object of the present invention to provide a novel halogenated biotin-modified dimer capable of performing imaging diagnosis or treatment. According to the present invention, a compound represented by the following formula (1) or a salt thereof is provided: wherein L1 represents a trivalent linking group, L2 represents a divalent linking group, Hal represents a halogen, p represents an integer of 1 to 5, and q, r, s, and t each independently represent an integer of 1 to 8.Type: ApplicationFiled: April 13, 2021Publication date: August 3, 2023Applicants: THE UNIVERSITY OF TOKYO, SAVID THERAPEUTICS INC., FUKUSHIMA MEDICAL UNIVERSITYInventors: Motomu KANAI, Kenzo YAMATSUGU, Toshifumi TATSUMI, Tatsuhiko KODAMA, Akira SUGIYAMA, Masanobu TSUKAGOSHI, Yuzo TODA, Kohshin WASHIYAMA, Kazuhiro TAKAHASHI, Songji ZHAO, Naoyuki UKON, Miho SUZUKI
-
Patent number: 11510987Abstract: The present invention addresses the problem of providing an endocytosis enhancer comprising associates formed from a fluorescent protein. The fluorescent protein is preferably any one selected from the group consisting of a white fluorescent protein, a red fluorescent protein, a yellow fluorescent protein, a blue fluorescent protein and a green fluorescent protein. The endocytosis enhancer according to the present invention can enhance the cellular uptake of a drug, which is encapsulated in micelles each formed from a fluorescent-protein-supported carbosilane dendrimer, through endocytosis.Type: GrantFiled: August 7, 2019Date of Patent: November 29, 2022Assignees: Saitama University, QUARRYMEN & Co. Inc.Inventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Patent number: 11160877Abstract: The present invention relates to a targeting-type capsule for drug delivery systems. The present invention addresses the problem of providing a capsule for drug delivery systems by utilizing the reactivity of a thiol with an alkyl halide, wherein the capsule comprises a silole-containing carbosilane dendrimer and a labeling protein containing a target recognition site (e.g., green fluorescent protein), can include a biological polymer or another molecule therein, and can deliver the biological polymer or the like selectively into a target cell.Type: GrantFiled: November 27, 2018Date of Patent: November 2, 2021Assignees: Saitama University, QUARRYMEN & Co. Inc.Inventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Patent number: 10918726Abstract: The object of the present invention is to provide an aggregatable carrier material for drug delivery system and a micelle formed thereof. The present invention provides an aggregatable carrier material for drug delivery system, which is formed by utilizing the reaction between thiol group and alkyl halide. It is formed by using carbosilane dendrimers containing silole and labeled proteins such as green fluorescent protein in aqueous solvent or in mixed solvent of the aqueous solvent and organic solvent. The micelle composed of the material may incorporate compounds having a variety of molecular weight and biopolymers in the aqueous solvent.Type: GrantFiled: May 26, 2017Date of Patent: February 16, 2021Assignees: QUARRYMEN & Co. Inc., Saitama UniversityInventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Patent number: 10772973Abstract: The present invention is related to a targeted type shell for drug delivery system. The object of the present invention is to provide the targeted type shell for DDS, which comprises a carbosilane dendrimer containing a silole produced by which is formed by utilizing the reaction between thiol group and alkyl halide, and a targeted protein containing a labeled proteins such as green fluorescent protein with a target recognition site. The shell may incorporate compounds having a variety of molecular weight and biopolymers, and selectively deliver them into targeted cells.Type: GrantFiled: May 29, 2018Date of Patent: September 15, 2020Assignees: QUARRYMEN & Co. Inc., Saitama UniversityInventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Publication number: 20200203709Abstract: A non-aqueous electrolyte solution battery includes a positive electrode containing manganese dioxide and a carbon material; a negative electrode including one of lithium and a lithium alloy; a non-aqueous electrolyte solution; and a container configured to accommodate the positive electrode, the negative electrode, and the non-aqueous electrolyte solution. In a spectrum that is measured by performing Raman spectroscopic analysis with respect to the positive electrode by using argon laser at a wavelength of 514.5 nm, an average value of peak intensity ratios ID/IG of an intensity ID of a peak appearing in the vicinity of 1330 cm?1 to an intensity IG of a peak appearing in the vicinity of 1580 cm?1 satisfies a relationship of 0.5?ID/IG?1.3.Type: ApplicationFiled: February 27, 2020Publication date: June 25, 2020Inventors: Kohei WATANABE, Jun YAGISAWA, Miho SUZUKI, Kaoru YABUKI, Koji HARADA, Yushin ENDO
-
Publication number: 20190358333Abstract: The present invention addresses the problem of providing an endocytosis enhancer comprising associates formed from a fluorescent protein. The fluorescent protein is preferably any one selected from the group consisting of a white fluorescent protein, a red fluorescent protein, a yellow fluorescent protein, a blue fluorescent protein and a green fluorescent protein. The endocytosis enhancer according to the present invention can enhance the cellular uptake of a drug, which is encapsulated in micelles each formed from a fluorescent-protein-supported carbosilane dendrimer, through endocytosis.Type: ApplicationFiled: August 7, 2019Publication date: November 28, 2019Inventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Publication number: 20190151467Abstract: The present invention relates to a targeting-type capsule for drug delivery systems. The present invention addresses the problem of providing a capsule for drug delivery systems by utilizing the reactivity of a thiol with an alkyl halide, wherein the capsule comprises a silole-containing carbosilane dendrimer and a labeling protein containing a target recognition site (e.g., green fluorescent protein), can include a biological polymer or another molecule therein, and can deliver the biological polymer or the like selectively into a target cell.Type: ApplicationFiled: November 27, 2018Publication date: May 23, 2019Inventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Publication number: 20180362718Abstract: The present invention is related to a targeted type shell for drug delivery system. The object of the present invention is to provide the targeted type shell for DDS, which comprises a carbosilane dendrimer containing a silole produced by which is formed by utilizing the reaction between thiol group and alkyl halide, and a targeted protein containing a labeled proteins such as green fluorescent protein with a target recognition site. The shell may incorporate compounds having a variety of molecular weight and biopolymers, and selectively deliver them into targeted cells.Type: ApplicationFiled: May 29, 2018Publication date: December 20, 2018Inventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Publication number: 20170281782Abstract: The object of the present invention is to provide an aggregatable carrier material for drug delivery system and a micelle formed thereof. The present invention provides an aggregatable carrier material for drug delivery system, which is formed by utilizing the reaction between thiol group and alkyl halide. It is formed by using carbosilane dendrimers containing silole and labeled proteins such as green fluorescent protein in aqueous solvent or in mixed solvent of the aqueous solvent and organic solvent. The micelle composed of the material may incorporate compounds having a variety of molecular weight and biopolymers in the aqueous solvent.Type: ApplicationFiled: May 26, 2017Publication date: October 5, 2017Inventors: Miho Suzuki, Ken Hatano, Shojiro Yoshida, Yasuhiro Yamashita
-
Publication number: 20140163099Abstract: The objective of the present invention is to provide an antimicrobial composition that can be safely used with a broad range of foods and beverages, cosmetics, drugs, and other similar products while showing growth inhibition activity against a wide variety of microorganisms. The present invention relates to the antimicrobial composition comprising at least one cooling agent selected from the group consisting of menthyl 3-hydroxybutanoate, 2-methyl-3-(menthoxy)propane-1,2-diol, 2-(menthoxy)ethanol, 3-menthoxypropan-1-ol, 2-(2-menthoxyethoxy)ethanol, and menthyl glyoxylate.Type: ApplicationFiled: February 12, 2014Publication date: June 12, 2014Applicant: TAKASAGO INTERNATIONAL CORPORATIONInventors: Kenya ISHIDA, Tomoko YAMAMOTO, Miho SUZUKI
-
Publication number: 20130005807Abstract: The objective of the present invention is to provide an antimicrobial composition that can be safely used with a broad range of foods and beverages, cosmetics, drugs, and other similar products while showing growth inhibition activity against a wide variety of microorganisms. The present invention relates to the antimicrobial composition comprising at least one cooling agent selected from the group consisting of menthyl 3-hydroxybutanoate, 2-methyl-3-(menthoxy)propane-1,2-diol, 2-(menthoxy)ethanol, 3-menthoxypropan-1-ol, 2-(2-menthoxyethoxy)ethanol, and menthyl glyoxylate.Type: ApplicationFiled: June 29, 2012Publication date: January 3, 2013Applicant: TAKASAGO INTERNATIONAL CORPORATIONInventors: Kenya ISHIDA, Tomoko YAMAMOTO, Miho SUZUKI
-
Patent number: D944355Type: GrantFiled: May 15, 2020Date of Patent: February 22, 2022Assignee: Shimano Inc.Inventor: Miho Suzuki
-
Patent number: D944356Type: GrantFiled: May 15, 2020Date of Patent: February 22, 2022Assignee: Shimano Inc.Inventor: Miho Suzuki
-
Patent number: D990616Type: GrantFiled: November 12, 2020Date of Patent: June 27, 2023Assignee: Shimano Inc.Inventors: Miho Suzuki, Akira Nago
-
Patent number: D1010064Type: GrantFiled: June 7, 2021Date of Patent: January 2, 2024Assignee: Shimano Inc.Inventor: Miho Suzuki